Phase I Study of Pharmacokinetics and Safety of Ravidasvir in Combination With Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Participants
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Danoprevir/ritonavir (Primary) ; Ravidasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Ascletis
- 15 Nov 2017 Planned End Date changed from 1 Oct 2017 to 1 Feb 2018.
- 15 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
- 20 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Oct 2017.